United Therapeutics Corporation (NASDAQ:UTHR) Stock Quotes and News

United Therapeutics Corporation (UTHR) 68.55 -0.66

Price Open:	65.99	Day's Range:	0.00000 - 69.61000
Price Close:	65.42	52wk Range:	0.00000 - 69.61000
Price Day Change:	-0.66	Volume:	405,569
Price % Change:	-1.01	Market Cap:	3.219B
Bid:	50.00000	PE Ratio:	11.65
Ask:	68.55000	EPS Diluted:	5.617

Trade UTHR NOW!

The Latest On UTHR

Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest ROA 6/17/13 4:08am

Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio 5/24/13 4:04am

13 Drugs Pending FDA Approval in 2013 3/26/13 1:19pm

Mid-Morning Market Update: Markets Rise On Cyprus Deal, Dollar General Posts Higher Profit 3/25/13 11:03am

Benzinga's Top Pre-Market Losers 3/25/13 8:39am

United Therapeutics Receives Second CRL from FDA for Oral Treprostinil NDA 3/25/13 5:49am

Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry With The Highest EPS 3/12/13 4:40am

UPDATE: Deutsche Bank Reiterates Hold Rating, Raises PT on United Therapeutics Corporation on Cut Expense Numbers 2/27/13 11:44am

Earnings Scheduled For February 26, 2013 2/26/13 5:24am

A Peek Into The Market Before The Trading Starts 2/4/13 8:10am

United Therapeutics Authorizes Additional $420M Share Buyback 2/4/13 7:03am

Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Cash 1/8/13 5:07am

Press Releases

Critical Alerts For Ford, Hologic, United Therapeutics, Apollo Group, and Zillow Released By InvestorsObserver 5/13/13 Newswire

United Therapeutics Corporation Reports First Quarter 2013 Financial Results 4/25/13 Newswire

United Therapeutics Corporation To Announce First Quarter 2013 Financial Results Before Market Open On Thursday, April 25, 2013 4/18/13 Newswire

United Therapeutics Announces Receipt Of Second Complete Response Letter For Oral Treprostinil NDA 3/25/13 Newswire

United Therapeutics Corporation Reports 2012 Fourth Quarter and Annual Financial Results 2/26/13 Newswire

United Therapeutics Corporation To Announce Fourth Quarter And Annual 2012 Financial Results Before Market Open On Tuesday, February 26, 2013 2/19/13 Newswire

United Therapeutics Announces FDA Acceptance of Resubmission of Oral Treprostinil NDA 2/14/13 Newswire

United Therapeutics Announces Additional $420 Million Share Repurchase Program 2/4/13 Newswire

Get the latest UTHR stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for United Therapeutics Corporation stock price.

Partner Headlines

Setback for Pluristem Therapeutics - Analyst Blog 6/5/13

Positive Data on Bayer Candidate - Analyst Blog 5/23/13

Bayer Files Riociguat in Japan - Analyst Blog 5/21/13

Super-Fast Growing Mid-Cap Growth Stocks with Explosive Returns 5/9/13

Indexes Recover Early Losses As Turnover Picks Up 4/30/13

Major Averages End Near Highs But Volume Lacks Conviction 4/29/13

Earnings Miss at UTHR - Analyst Blog 4/29/13

Biogen, Celgene, Other Top Biotech Earnings Mixed 4/25/13

Stocks Defend Broad Advance; Western Digital, Teradyne Surge 4/25/13

3 Top Biotechs Report Sharply Different Quarters 4/25/13

Biotechs Near Highs In A Week Of Key Earnings Reports 4/24/13